Septorhinoplasty Post-operative Pain Control With SPG Nerve Block

• Status: Not yet recruiting
• Trial end date: 2024-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Maxillary nerve blocks have been shown to significantly reduce post-operative pain and analgesic intake during the 24-hour period following sinus surgery. This randomized, double-blinded, placebo-controlled study will investigate blocks of the pterygopalatine fossa using a suprazygomatic approach during septorhinoplasty surgery. It is the investigator's hypothesis that this technique will result in decreased post-operative pain and opioid use, and the morbidity associated with it.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Florida
• Treatments: Dexamethasone; Ropivacaine

Criteria

Inclusion Criteria:

• Patient presenting for open or endoscopic septorhinoplasty

• Age 18-80

• Normal oral food and water intake before surgery

• ASA physical classification 1-3

Exclusion Criteria:

• Refusal to consent

• Patients without a cellular phone or who are unable to accept text messages

• Allergy to opioid narcotics

• ASA physical classification of 4 or higher

• Patient requires other surgery in addition to septorhinoplasty

• Age > 80 or <18

• Any underlying chronic pain condition or ongoing opioid use over the preceding 3 months

• Presence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for block placement.

• Presence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for research participation.

• Pregnant women